About Actando
Actando is a Technology company based in Geneve (Switzerland) founded in 2010, and was acquired by Red Nucleus in June 2022. Learning and decision-making tools are supplied for the pharmaceutical sector. Actando offers products and services including UNIFY, DirectusPRO, iTakeControl, UNIFY GameLab, and Red Nucleus Training Institute. Its focus areas include Enterprise Applications, HRTech, LMS and Gamification Based.
Company details
Actando was founded in 2010 and is based in Geneva, Switzerland. Decision-making tools are offered by the company for the pharmaceutical industry, including implementations for market attractiveness, competitive strengths, strategic portfolio analysis, resource optimization, carryover calculations, and financial portfolio reviews. Learning solutions provided encompass serious games, e-learning modules, blended learning programs, and assessments. Operations focus on supporting commercial excellence in pharma.
- Headquarters Geneve, Switzerland
- Stage Acquired
- SectorsTechnology
- Phone•••• ••••
- Website actando.com
- Social LinkedIn X
- Acquired by Red Nucleus (Jun 2022)
- Investors
- Acquired byRed Nucleus
(Jun 2022)
Products & Services of Actando
Actando offers a comprehensive portfolio of products and services, including UNIFY, DirectusPRO, iTakeControl, UNIFY GameLab, and Red Nucleus Training Institute.
Digital tool for interactive learning and assessment delivery.
Platform for managing and enhancing training experiences.
Solution for interactive content and learner interaction.
Authoring platform for game-based learning reinforcement.
Provider of on-demand foundational skills training programs.
Investors in Actando
Actando has secured backing from 1 investor. Prominent investors backing the company include Red Nucleus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Advisory, scientific, and medical communications provided for pharmaceutical industry. | 2014 | rednucleus.com | Yardley, United States |
Investor details for Actando
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Actando
2 dated milestones of Actando across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Actando is founded.
- Exit Acquired by Red Nucleus.
Web traffic of Actando
Websites that share an audience with Actando (actando.com).
Websites whose visitors overlap most with Actando. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mylearningcommunity.com | mylearningcommunity.com | 100% | #4,285,312 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Actando
Complete news archive for Actando
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Actando
Actando was founded in 2010.
Actando is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Actando was founded in 2010 and is based in Geneva, Switzerland. Decision-making tools are offered by the company for the pharmaceutical industry, including implementations for market attractiveness, competitive strengths, strategic portfolio analysis, resource optimization, carryover calculations, and financial portfolio reviews. Learning solutions provided encompass serious games, e-learning modules, blended learning programs, and assessments. Operations focus on supporting commercial excellence in pharma.
Actando offers UNIFY, DirectusPRO, iTakeControl, UNIFY GameLab, and Red Nucleus Training Institute.
Actando has 1 investor. Key investors include Red Nucleus.
Yes. Actando was acquired by Red Nucleus in June 2022.